Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422981
Status:
COMPLETED
Last Update Posted:
2012-10-24
First Post:
2007-01-16
Brief Title:
Safety Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
Sponsor:
Allon Therapeutics
Organization:
Allon Therapeutics
Study Overview
Official Title:
A Phase 2 Double-Blind Placebo-Controlled Study to Evaluate the Safety Tolerability and Effect on Cognitive Function of AL-108 After 12 Weeks of Intranasal Administration in Subjects With Mild Cognitive Impairment
Status:
COMPLETED
Status Verified Date:
2012-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out if different doses of Investigational Drug are safe tolerable and if they have an effect on Mild Cognitive Impairment MCI
Detailed Description:
Pre-Clinical experiments indicate the AL-108 compound has neuroprotective cognitive protective and neurotrophic properties therefore the compound could be tested in a variety of human diseases Human diseases include Cognitive impairment associated with aging or neurodegenerative diseases such as Alzheimers Disease
This clinical trial aims at providing the dose rationale as well as safety and tolerability information for AL-108 as evaluated after 12 weeks of intranasal administration in subjects with Mild Cognitive Impairment MCI
There are currently no drugs approved for the treatment of MCI nor accepted treatment or standard treatment approach
This clinical trial aims at providing the dose rationale as well as safety and tolerability information for AL-108 as evaluated after 12 weeks of intranasal administration in subjects with Mild Cognitive Impairment MCI
There are currently no drugs approved for the treatment of MCI nor accepted treatment or standard treatment approach
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None